Rinvoq (Upadacitinib)

**Product type:** Human Prescription Drug

**Active ingredient:** UPADACITINIB

**Strength:** 45 mg/1

**Dosage form:** Tablet, Extended Release

**Route:** Oral

**Labeler:** AbbVie Inc.

**Marketing category:** NDA (NDA211675)

**Pharmacologic class:** Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]